C-MED-100

an aqueous extract from Uncaria tomentosa, enhances DNA repair & immune function

Networked: 4 relevant articles (0 outcomes, 1 trials/studies)

1.	Leukopenia 04/01/2000 - "In this study, the effect of C-Med-100 in the treatment of chemically induced leukopenia was evaluated in a rat model. "
2.	Neoplasms (Cancer) 01/15/2005 - "Here we characterize the active ingredients of a water-soluble Cat's Claw extract called C-Med-100 as inhibiting cell growth without cell death thus providing enhanced opportunities for DNA repair, and the consequences thereof, such as immune stimulation, anti-inflammation and cancer prevention. "
3.	Necrosis 03/01/2006 - "For this purpose skin cultures were treated with or without 5 mg/mL C-Med-100, irradiated with 0-100 mJ/cm2 UVB, and microscopically analysed for necrosis as well as the level of pyrimidine dimers using immunofluorescent TT-dimer antibody staining. "
4.	Inflammation (Inflammations) 01/15/2005 - "Here we characterize the active ingredients of a water-soluble Cat's Claw extract called C-Med-100 as inhibiting cell growth without cell death thus providing enhanced opportunities for DNA repair, and the consequences thereof, such as immune stimulation, anti-inflammation and cancer prevention. "
5.	Body Weight (Weight, Body) 02/01/2000 - "In addition, no body weight, food consumption, organ weight and kidney, liver, spleen, and heart pathological changes were found to be associated with C-MED-100 treatment."